To understand the relationship between ACTL6A and p21Cip1 level, and the cancer cell phenotype, we treated cells with combinations of ACTL6A- and p21Cip1-siRNA and monitored the impact on cell invasion. This evidence concerns the gene CDKN1A and cancer.